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Abstract
Pigmentary mosaicism of Ito (PMI) is a skin abnormality often characterized by hypopigmentation of skin, following,
in most cases, the Blaschko lines, usually associated with extracutaneous abnormalities, especially abnormalities of
the central nervous system (CNS). It is suggested that this pattern arises from the presence and migration of two cell
lineages in the ectoderm layer during the embryonic period and embryonic cell migration, with different gene expres-
sion profiles associated with pigmentation. Several types of chromosomal aberrations, with or without mosaicism,
have been associated with this disorder. This study comprised clinical description and cytogenetic analysis of a child
with PMI. The G-banded karyotype analysis revealed a supernumerary marker chromosome in 76% of the analyzed
metaphases from peripheral blood lymphocytes. Array genomic hybridization analysis showed a copy number gain
between 3q26.32-3q29, of approximately 20.5 Mb. Karyotype was defined as 47,XX,+mar[38]/46,XX[12].arr
3q26.32-3q29(177,682,859- 198,043,720)x4 dn. Genes mapped in the overlapping region among this patient and
three other cases described prior to this study were listed and their possible involvement on PMI pathogenesis is dis-
cussed.
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Pigmentary mosaicism of Ito (PMI) is a rare and
multisystem neuroectodermal disorder characterized by cu-
taneous lesions consisting of hypopigmented zones or spots
with irregular borders, patches, and whorls following the
lines of Blaschko on the back, arms, and legs. Other fea-
tures include ophthalmologic defects, such as strabism and
nystagmus, focal alopecia or trichorrhexis, musculoskeletal
abnormalities such as hemihyperplasia, bifid thumb, sco-
liosis and finger anomalies, oral manifestations such as
dental hypoplasia and dysplasia, heart defects, hearing im-
pairment, abnormalities of the CNS and neurodevelop-
mental anomalies (Cappanera et al., 2011).
PMI is a relatively common phenotype. Pascual-
Castroviejo et al. (1988) reported a frequency of one in ev-
ery eight to ten thousand new patients in a general pediatric
hospital, and one in every thousand new patients in the pe-
diatric neurology service in Spain. The genetic mechanisms
of PMI are not completely understood and its underlying
pathogenesis remains unclear. Pigment production, stor-
age, and distribution are controlled by many genes and can,
therefore, be disturbed by many different chromosomal
mosaic rearrangements or gene mutations and are associ-
ated with wide phenotypic variability. A wide range of
cytogenetic abnormalities involving different chromo-
somes has been reported in PMI patients (Cappanera et al.,
2011).
This study comprised the clinical description and
cytogenetic analysis of an individual with PMI. The patient
is a girl born to non-consanguineous parents of Afro-Bra-
zilian and Iberian origins; the father was 33 and the mother
29 years old at conception. Pregnancy was uneventful, and
she was delivered at 37 weeks of gestational age by caesar-
ean section due to placenta previa, measuring 49 cm and
weighing 3,250 g. There was an initial delay in motor and
speech development, but she currently attends a regular
school with good performance. She also presented an atrial
septal defect, which was surgically corrected at the age of
two years, and pulmonary hypertension. She was first seen
at the age of 4 years for dysmorphologic evaluation. Physi-
cal examination revealed a stature of 106 cm, a weight of
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18.2 kg (both on 75th centile), and an OFC of 52 cm (nor-
mal), upslanting palpebral fissures, high palate, umbilical
hernia, and short metacarpals (3rd on right, 4th and 5th on
left) and metatarsals. She also presented hypertrichosis on
front, limbs, dorsum and vulva, in addition to areas of hypo
and hyperchromic pigmentation on the face and trunk, fol-
lowing the Blaschko lines, hence compatible with pig-
mentary mosaicism of Ito (Figure 1). At the age of six, she
had a traumatic fracture of the left humerus with surgical
correction, and a densitometry revealed normal BMD.
Health is otherwise described as good and at the age of
eight she kept presenting normal growth and school perfor-
mance. Complementary tests included hormonal evalua-
tions (FSH, LH, testosterone, E2, DHEA, 17- OH-pro-
gesterone), abdominal and pelvic ultrasound, skeletal
survey, and bone age assessment, all within normal range.
Chromosomal analysis was performed after
G-banding on metaphases from cultured peripheral blood
lymphocytes. A supernumerary marker chromosome was
observed in 38 out of 50 (76%) analyzed metaphases,
47,XX,+mar[38]/46,XX[12] (Figure 2a). The marker chro-
mosome, which had a primary constriction and arms of
similar length, was negative for pericentromeric hetero-
chromatin and nucleolar organizer region, as documented
by C-banding (Figure 2b) and NOR-staining (data not
shown), respectively. The parents had normal karyotypes.
Array genomic hybridization, using the Genome-
Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA,
USA), showed a copy number gain between 3q26.32-3q29,
of approximately 20.5 Mb (177,682,859-198,043,720 bp;
NCBI Build 37 [hg19]) (Figure 3A). This was confirmed by
allele peaks difference graphic composed by single nucleo-
tide polymorphism (SNP) oligonucleotides (Figure 3B). It
was possible to characterize this copy number gain as a
tetrasomy by copy number state graph (CN state = 4) (Fig-
ure 3C). After this analysis, the karyotype was defined as
47,XX,+mar[38]/46,XX[12].arr 3q26.32-3q29(177,682,
859-198,043,720)x4 dn.
Data from C-banding and array analysis did not re-
veal the presence of a centromere on this supernumerary
marker chromosome. Although we neither performed FISH
with -satellite DNA probe nor immunofluorescence for
centromeric proteins, the stability of this marker through
cell divisions pointed to the activation of a neocentromere,
as in previous reported analphoid markers derived from the
distal long arm of chromosome 3 (Gimelli et al., 2007;
Murthy et al., 2009; Teshima et al., 2000). In addition, con-
sidering that the most common mechanism for the forma-
tion of a neocentric marker chromosome is the de novo
inverted duplication of a distal chromosome segment (War-
burton, 2004), this marker most probably has arisen from
an inverted duplication of the terminal segment of the long
arm of chromosome 3.
A search for a copy number gain in this region was
done at the Database of Genomic Variants (DGV) and no
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Figure 1 - Facial and trunk views of the patient. Note hypertrichosis on front and dorsum, as well as areas of hypo and hyperchromic pigmentation follow-
ing the Blaschko lines.
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Figure 2 - Cytogenetic analysis. a) Partial karotype of the patient showing a supernumerary marker chromosome and normal chromosomes 3, b)
C-banding showing no staining on the marker chromosome. The black arrow points to the supernumerary marker chromosome.
Figure 3 - Array genomic hybridization results. A) array profile of chromosome 3: weighted log2 ratio plot, the red arrow points to the 20.5 Mb copy
number gain between 3q26.32-3q29; B) array profile of chromosome 3: the allele difference plot is also highlighted by the red arrow; C) array profile of
chromosome 3: copy number state graph showing the 3q26.32-3q29 tetrasomy; D) schematic figure of the copy number gain at 3q, blue bars indicate the
range in three cases previously reported and in our patient.
copy number variant (CNVs) was found that overlapped by
more than 50% in size with this case. At the Database of
Chromosomal Imbalance and Phenotype in Humans
(DECIPHER) there are nine cases reported that overlap this
segment. However, the phenotype is viable only in six
cases (4430, 249448, 249410, 255465, 3765 and 1949) and
does not match with PMI.
There are three cases of PMI reported with a supernu-
merary marker chromosome originating from 3q, detected
in mosaic form in fibroblast cell culture (Portnoi et al.,
1999; Gimelli et al., 2007; Murthy et al., 2008). However, a
3q marker was detected on lymphocyte cells only in the pa-
tient described by Portnoi et al. (1999). In the present case,
fibroblast cell culture was unsuccessful. Clinical features of
four cases, together with the patient here described, are typ-
ical of PMI including multiple congenital anomalies and
Blaschko lines.
Array results from blood cells of our patient showed a
copy number gain from 3q26.32-3q29, which involves 126
genes. Breakpoints are different among all patients, rang-
ing from q22.3 to q27, involving approximately the follow-
ing chromosome locations: 183,634,210-197,289,527
[hg19] (Portnoi et al., 1999), 137,299,271-198076, 949
[hg19] (Gimelli et al., 2007) and 160,030,000-198,290,000
[hg19] (Murthy et al., 2008). However, there is an overlap-
ping region among all patients, which ranges from q27.1 to
q29 (fig. 3d), comprising 107 genes. From these, we con-
sider six genes as possibly involved in the PMI patho-
genesis in our patient due to their biological function and
expression pattern.
DVL3 (dishevelled segment polarity protein 3, Gene
ID: 1857) gene encodes a protein involved in several mo-
lecular signaling pathways and in biological processes like
neural crest differentiation and melanogenesis. This bio-
logical process of melanin pigment synthesis is controlled
by complex and multiple pathways of genes. Melanin-
containing melanosomes move from the perinuclear region
to the dendrite tips and are transferred to keratinocytes by a
still not well-characterized mechanism.
TP63 (tumor protein p63, Gene ID: 8626) gene en-
codes a member of the p53 family of transcription factors
and plays a role in several biological processes like ecto-
derm and mesoderm interaction, embryonic limb morpho-
genesis, epidermal cell division, epithelial cell develop-
ment, keratinocyte differentiation and proliferation. It is
well known that mutations in this gene are associated with a
group of syndromes characterized by ectodermal and limb
anomalies and dysmorphic features.
PIK3CA (phosphatidylinositol-4,5-bisphosphate
3-kinase, catalytic subunit alpha, Gene ID: 5290) gene is
involved in different biological processes like endothelial
cell migration, epidermal and fibroblast growth factor re-
ceptor signaling pathway. LEPREL1 (leprecan-like 1, Gene
ID: 55214) gene encodes an enzyme member of the prolyl
3-hydroxylase subfamily of 2-oxo-glutarate-dependent
dioxygenases, which plays a critical role in collagen meta-
bolic process. Mutations in this gene are associated with
nonsyndromic severe myopia and cataract. AP2M1 (adap-
tor-related protein complex 2, mu 1 subunit, Gene ID:
1173) gene is also involved in several biological processes
and participates in the epidermal growth factor receptor
(EGFR) signaling pathway.
SOX2 (SRY (sex determining region Y)-box 2, Gene
ID: 6657) gene encodes a member of the SRY-related
HMG-box (SOX) family of transcription factors involved
in the regulation of embryonic development (eye, cerebral
cortex and forebrain neuronal differentiation) and in cell
fate determination. Mutations in this gene have been asso-
ciated with optic nerve hypoplasia and syndromic micro-
phthalmia.
PMI has been associated with different chromosomal
anomalies. Including the patient described here, there are
four cases with PMI and copy number gains of the q termi-
nal region of chromosome 3. This reinforces the hypothesis
that overexpression of genes present in this region, proba-
bly one or more of the genes described above, could be in-
volved in PMI pathogenesis.
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